Lifecare ASA

Share Issue/Capital Change • May 21, 2024

LIFE – EX. SUBSCRIPTION RIGHTS TODAY

Issuer: Lifecare ASA Ex. date: 21 May 2024 Type of corporate action: Preferential rights issue Other information: The shares in Lifecare ASA will from today, 21 May 2024, be traded exclusive of the right to receive subscription rights for shares in the preferential rights issue announced on 25 April 2024.

This information is published in accordance with the requirements of the Continuing Obligations for Euronext Growth Oslo.

About us

Lifecare ASA is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's main focus is to bring the next generation of Continuous Glucose Monitoring ("CGM") systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on the sensor body for read-out of pressure variations. Lifecare's sensor technology is referred to as "Sencell" and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, Lifecare ASA, joacim.holter@lifecare.no, +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs, asle.wingsternes@lifecare.no, +47 41 61 42 52

This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication at 2024-05-21 08:00 CEST.